Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 8;13(13):3977.
doi: 10.3390/jcm13133977.

Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects

Chahat Suri  1   2 , Babita Pande  3 , Tarun Sahu  3 , Lakkakula Suhasini Sahithi  4 , Henu Kumar Verma  2
Affiliations
Review

Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects

Chahat Suri et al. J Clin Med. .

Abstract

In recent years, remarkable strides have been made in the management of gastrointestinal disorders, transforming the landscape of patient care and outcomes. This article explores the latest breakthroughs in the field, encompassing innovative diagnostic techniques, personalized treatment approaches, and novel therapeutic interventions. Additionally, this article emphasizes the use of precision medicine tailored to individual genetic and microbiome profiles, and the application of artificial intelligence in disease prediction and monitoring. This review highlights the dynamic progress in managing conditions such as inflammatory bowel disease, gastroesophageal reflux disease, irritable bowel syndrome, and gastrointestinal cancers. By delving into these advancements, we offer a glimpse into the promising future of gastroenterology, where multidisciplinary collaborations and cutting-edge technologies converge to provide more effective, patient-centric solutions for individuals grappling with gastrointestinal disorders.

Keywords: artificial intelligence; diagnosis; gastrointestinal disorders; management; theraputics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Timeline for the Gastrointestinal Care Advancement.
Figure 2
Figure 2
The Precision Medicine Paradigm.
Figure 3
Figure 3
Visual representation of the integration of genetic and microbiome data in personalized treatment strategies.
Figure 4
Figure 4
Schematic illustrating the application of artificial intelligence in the preoperative, intraoperative and postoperative stages of the disease.
See this image and copyright information in PMC

References

    1. Mukhtar K., Nawaz H., Abid S. Functional gastrointestinal disorders and gut-brain axis: What does the future hold? World J. Gastroenterol. 2019;25:552–566. doi: 10.3748/wjg.v25.i5.552. - DOI - PMC - PubMed
    1. Onwuzo S., Boustany A., Khaled Abou Zeid H., Hitawala A., Almomani A., Onwuzo C., Lawrence F., Monteiro J.M., Ndubueze C., Asaad I., et al. Prevalence and Risk Factors Associated with Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study. Cureus. 2023;15:e34088. doi: 10.7759/cureus.34088. - DOI - PMC - PubMed
    1. Seyedian S.S., Nokhostin F., Malamir M.D. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J. Med. Life. 2019;12:113–122. doi: 10.25122/jml-2018-0075. - DOI - PMC - PubMed
    1. Mitropoulou M.-A., Fradelos E.C., Lee K.Y., Malli F., Tsaras K., Christodoulou N.G., Papathanasiou I.V. Quality of Life in Patients with Inflammatory Bowel Disease: Importance of Psychological Symptoms. Cureus. 2022;14:e28502. doi: 10.7759/cureus.28502. - DOI - PMC - PubMed
    1. Lee H.H., Gweon T.-G., Kang S.-G., Jung S.H., Lee K.-M., Kang S.-B. Assessment of Fatigue and Associated Factors in Patients with Inflammatory Bowel Disease: A Questionnaire-Based Study. J. Clin. Med. 2023;12:3116. doi: 10.3390/jcm12093116. - DOI - PMC - PubMed

LinkOut - more resources